Metraipolis › archive › dc_4a6288e290dc
Efficacy and Safety of Avatrombopag Treatment in Immune Thrombocytopenia Patients in Poland: A Multicenter Study — Europe PMC PMID:42440844
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42440844
- DOI
- 10.1055/a-2868-3290
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T10:46:41.766Z
- SHA-256 of the archived text
4a2c8bccb3bb90c8e546b8ea3d492bc6ff86dd23d690d5379ee753de97bd88e7- Stable URL of this page
https://metraipolis.com/documento/dc_4a6288e290dc
How to cite
Efficacy and Safety of Avatrombopag Treatment in Immune Thrombocytopenia Patients in Poland: A Multicenter Study — Europe PMC PMID:42440844 — Europe PMC (en), https://europepmc.org/article/MED/42440844 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4a6288e290dc (Metraipolis archive dc_4a6288e290dc, sha256 4a2c8bccb3bb90c8e546b8ea3d492bc6ff86dd23d690d5379ee753de97bd88e7)
BibTeX
@misc{dc4a6288e290dc,
title = {Efficacy and Safety of Avatrombopag Treatment in Immune Thrombocytopenia Patients in Poland: A Multicenter Study — Europe PMC PMID:42440844},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42440844},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4a6288e290dc; sha256 4a2c8bccb3bb90c8e546b8ea3d492bc6ff86dd23d690d5379ee753de97bd88e7},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42440844. Agents can read the archived copy with the MCP tool read_document.